According to a new study, a diabetes drug could help fight Parkinson's disease. The study has been published in the journal Plos One. It has been found in the study that people who took glitazone pills had less chances of developing Parkinson's than patients who take other diabetes drugs.

Approximately 127,000 people in the UK are suffering from Parkinson's disease, which can cause slow movement, tremor and stiff muscles. It has been found by scientists that fewer people developed Parkinson's in the group taking glitazone; however, the drug is not effective for long period.

According to Dr Ian Douglas, lead researcher at the London School of Hygiene and Tropical Medicine, it is generally assumed that negative side-effects are linked to medications; however, there could also be unintended benefits at times.

He added that their findings have come up with unique evidence, so they are looking forward to do further investigation into potential drug treatments for the condition. According to him, in the earliest stages of the disease when nerves are not damaged to a large extent, such therapies would be most effective.

However, scientists say healthy people should not take these drugs, for the reason that glitazone drugs have earlier been connected to serious heart and bladder problems.

According to Dr Arthur Roach, from the charity Parkinson's UK, "Hopefully the results of this study will spark further research into developing drugs that work in a similar way to glitazone drugs, and have the ability to reduce someone's chance of developing Parkinson's".